Acadia Healthcare Company, Inc. (ACHC)
NASDAQ: ACHC · Real-Time Price · USD
15.15
+0.82 (5.72%)
Jan 22, 2026, 4:00 PM EST - Market closed
Acadia Healthcare Company Stock Forecast
Stock Price Forecast
The 14 analysts that cover Acadia Healthcare Company stock have a consensus rating of "Buy" and an average price target of $20.07, which forecasts a 32.48% increase in the stock price over the next year. The lowest target is $13 and the highest is $30.
Price Target: $20.07 (+32.48%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Acadia Healthcare Company stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 4 | 4 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 2 | 3 | 3 | 3 | 5 | 6 |
| Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 12 | 12 | 12 | 13 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $34 → $15 | Strong Buy → Hold | Downgrades | $34 → $15 | -0.99% | Jan 22, 2026 |
| TD Cowen | TD Cowen | Strong Buy Maintains $25 → $22 | Strong Buy | Maintains | $25 → $22 | +45.21% | Jan 16, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $19 → $17 | Buy | Maintains | $19 → $17 | +12.21% | Jan 14, 2026 |
| Mizuho | Mizuho | Hold Maintains $22 → $17 | Hold | Maintains | $22 → $17 | +12.21% | Dec 18, 2025 |
| Barclays | Barclays | Hold Maintains $17 → $14 | Hold | Maintains | $17 → $14 | -7.59% | Dec 4, 2025 |
Financial Forecast
Revenue This Year
3.36B
from 3.15B
Increased by 6.50%
Revenue Next Year
3.51B
from 3.36B
Increased by 4.38%
EPS This Year
2.13
from 2.78
Decreased by -23.37%
EPS Next Year
1.97
from 2.13
Decreased by -7.64%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.5B | 3.7B | |||
| Avg | 3.4B | 3.5B | |||
| Low | 3.2B | 3.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 10.5% | 8.9% | |||
| Avg | 6.5% | 4.4% | |||
| Low | 1.9% | -2.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.52 | 2.36 | |||
| Avg | 2.13 | 1.97 | |||
| Low | 1.88 | 1.45 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -9.4% | 10.9% | |||
| Avg | -23.4% | -7.6% | |||
| Low | -32.3% | -31.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.